Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 15, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Social Anxiety Disorder
Interventions
BEHAVIORAL

Virtual Reality Exposure Therapy

Participants receive structured Virtual Reality Exposure Therapy sessions using a VR headset. The intervention provides simulated social situations (e.g., public speaking, group interactions) to gradually expose participants to anxiety-provoking scenarios. The sessions are guided and standardized to target symptoms of social anxiety disorder.

DRUG

Sertraline (Oral Antidepressant)

Participants receive pharmacological treatment with Sertraline, a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for social anxiety disorder. Dosage and administration will follow clinical guidelines and physician judgment.

Trial Locations (1)

41000

RECRUITING

Kocaeli University Hospital - Department of Child and Adolescent Psychiatry, Kocaeli

All Listed Sponsors
collaborator

Kocaeli University

OTHER

lead

Emine Kanmaz

OTHER